Why A2 Milk, Actinogen Medical, Karoon Energy, and Race Oncology shares are rising

These shares are avoiding the market weakness on Wednesday. But why?

| More on:
a man in a business suite throws his arms open wide above his head and raises his face with his mouth open in celebration in front of a background of an illuminated board tracking stock market movements.

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The S&P/ASX 200 Index (ASX: XJO) is having a tough time on Wednesday after a stronger than expected inflation reading. In afternoon trade, the benchmark index is down 1% to 7,758.4 points.

Four ASX shares that are not letting that hold them back are listed below. Here's why they are rising:

A2 Milk Company Ltd (ASX: A2M)

The A2 Milk share price is up over 2% to $6.66. This appears to have been driven by a broker note out of Citi this morning. In response to very positive industry data, the broker is feeling confident about the company's outlook. Particularly given the improving birth rate outlook in China and its belief that domestic brands are not going to limit its growth. As a result, it has reaffirmed its buy rating and $7.85 price target on its shares. This implies potential upside of almost 18% for investors over the next 12 months.

Actinogen Medical Ltd (ASX: ACW)

The Actinogen Medical share price is up 19% to 3.7 cents. This morning, this biotech announced that positive trial data relating to its Xanamem product in patients with elevated blood pTau. The company's chief medical officer, Dr Dana Hilt, said: "To our knowledge Xanamem is the first drug of this class to have such compelling data. The previously published PET study highlighted just how effective Xanamem is at reaching its target enzyme in the brain at safe and well tolerated doses of 5 and 10 mg/day. No other inhibitor of 11β-HSD1 has ever demonstrated robust central nervous system target engagement in this direct way."

Karoon Energy Ltd (ASX: KAR)

The Karoon Energy share price is up 2% to $1.80. This may be a delayed reaction to the energy company's drilling and operational update yesterday. That update confirmed that the Bauna Project restarted production on 11 June as scheduled. In addition, it advised that Who Dat production is currently averaging over 40,000 barrels of oil equivalent (boe) per day on a gross basis. As a result, Karoon Energy expects Who Dat production for the quarter ended 30 June 2024 to be approximately 0.8 million boe.

Race Oncology Ltd (ASX: RAC)

The Race Oncology share price is up 6% to $1.81. Investors have been buying this clinical stage biopharmaceutical company's shares following the release of a positive announcement relating to its RC220 bisantrene formulation. The company is advancing RC220 to address the high unmet needs of patients across multiple oncology indications. According to the release, toxicology and safety pharmacology studies showed no unexpected or unacceptable toxicities. This means that the completed data package supports the use of RC220 bisantrene in human clinical trials.

Citigroup is an advertising partner of The Ascent, a Motley Fool company. Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has no position in any of the stocks mentioned. The Motley Fool Australia has recommended A2 Milk. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Share Gainers

Two lab workers fist pump each other.
Healthcare Shares

Guess which ASX 300 healthcare stock just rocketed 20% on BIG earnings growth

Investors are piling into the ASX 300 healthcare stock on Monday. But why?

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why Ansell, GQG, Mayne Pharma, and Star shares are charging higher today

These shares are starting the week on a positive note. But why?

Read more »

People sit in rollercoaster seats with expressions of fear, terror and exhilaration as it goes into a steep downward descent representing the Novonix share price in FY22
Share Gainers

Here are the top 10 ASX 200 shares today

ASX investors had a rough end to the trading week this Friday.

Read more »

Siblings jumping on a trampoline.
Share Gainers

These 3 ASX 200 stocks are charging higher this week. Own any?

Investors have been piling into these ASX 200 stocks this week. But why?

Read more »

A young woman holding her phone smiles broadly and looks excited, after receiving good news.
Share Gainers

Why Domino's, Nick Scali, REA, and Sigma shares are charging higher today

These shares are ending the week on a high. Let's see why investors are bidding them higher today.

Read more »

a young woman raises her hands in joyful celebration as she sits at her computer in a home environment.
Share Gainers

Why BWP, Magellan, News Corp, and Winsome shares are pushing higher today

These shares are having a better day than most on Thursday. But why?

Read more »

Three happy office workers cheer as they read about good financial news on a laptop.
Share Gainers

Here are the top 10 ASX 200 shares today

The ASX was back in form this hump day...

Read more »

A boy stands firm on a rocky cliff holding a rocket in each hand and looking up toward the sky, anticipating flying into space.
Resources Shares

Up 864% in a year, how this ASX mining stock is primed to keep rocketing in 2025

The ASX mining stock looks to be in a sweet spot amid export bans from China and Russia.

Read more »